Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors

Sibaud, V; Beylot-Barry, M; Protin, C; Vigarios, E; Recher, C; Ysebaert, L

Sibaud, V (corresponding author), Inst Claudius Regaud, Oncodermatol Dept, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France.; Sibaud, V (corresponding author), Inst Univ Canc Toulouse Oncopole, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020; 21 (6): 799

Abstract

The development of Bruton's tyrosine kinase (BTK) inhibitors represents a major breakthrough in the treatment of chronic lymphocytic leukemia and othe......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索